LCM
EW icon

LCM Capital Management’s Edwards Lifesciences EW Stock Holding History

LCM Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Buy
2,729
+50
+2% +$4.12K 0.11% 99
2025
Q4 		$228K Sell
2,679
-110
-4% -$9.03K 0.11% 92
2025
Q3 		$217K Buy
2,789
+6
+0.2% +$469 0.1% 97
2025
Q2 		$218K Buy
2,783
+23
+0.8% +$1.72K 0.11% 97
2025
Q1 		$200K Buy
+2,760
New +$198K 0.12% 97
2024
Q3 		– Sell
-2,541
Closed -$235K – 99
2024
Q2 		$235K Buy
2,541
+123
+5% +$10.9K 0.15% 79
2024
Q1 		$231K Buy
+2,418
New +$203K 0.15% 81

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

LCM Capital Management's EW Position: Q1 2026 in Review

LCM Capital Management increased its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, buying an estimated $4.12K and bringing the position to 2,729 shares worth $219K. The position accounts for 0.11% of the portfolio, ranked #99.

LCM Capital Management first reported a position in EW in Q1 2024 and has held it in 7 quarters since. The position peaked at $235K in Q2 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • LCM Capital Management held 2,729 shares of Edwards Lifesciences worth $219K as of Q1 2026.
  • LCM Capital Management bought 50 Edwards Lifesciences shares in Q1 2026, an estimated $4.12K.
  • Edwards Lifesciences made up 0.11% of LCM Capital Management's portfolio in Q1 2026, its #99 holding.
  • LCM Capital Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 7 quarters since.
  • LCM Capital Management's Edwards Lifesciences position peaked at $235K in Q2 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.